TTrialPathMatch Me to Trials
← Back to trials
RecruitingCOPD Exacerbation

Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong

Eligible age

40+ yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study aims to develop predictive models for patients with a diagnosis of COPD at discharge of an index admission on these outcomes using machine learning: Primary outcome: Early admission Secondary outcomes: 1. Frequent readmission 2. Composite outcome (Early + Frequent readmissions) 3. Mortality 4. Longstayers

Sponsor: Chinese University of Hong Kong

You may qualify if…

  • ≥40 years
  • Patients are discharged from 2016 -2022
  • Discharge Diagnosis: Using the Discharge Diagnosis ICD Codes found in the Primary Diagnosis to determine if a patient has COPD
  • Validated against Spirometry results (for patient with a spirometry reading):
  • Spirometry reading taken from anytime point before. Patient should have Post FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. If Post FEV1/FVC is not available, we will check if patients have a Pre FEV1/FVC value, and will also include patients with Pre FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings.

You may not qualify if…

  • Admission diagnosis due to causes other than COPD

Source: ClinicalTrials.gov · NCT05825014 · last updated 2026-03-18